Second line treatment of acromegaly: Pasireotide or Pegvisomant?
Sabrina Chiloiro, Antonio Bianchi, Antonella Giampietro, Alfredo Pontecorvi, Gérald Raverot, Laura De Marinis
Topics & Concepts
AcromegalyPasireotidePegvisomantMedicineDiseaseSomatostatinInternal medicineOctreotideOncologyEndocrinologyGrowth hormoneHormonePituitary Gland Disorders and TreatmentsGrowth Hormone and Insulin-like Growth FactorsNeuroendocrine Tumor Research Advances